[1]
Gupta A, Abrahimi A, Patel A. Felty syndrome: a case report. Journal of medical case reports. 2021 May 27:15(1):273. doi: 10.1186/s13256-021-02802-9. Epub 2021 May 27
[PubMed PMID: 34039422]
Level 3 (low-level) evidence
[2]
Campion G, Maddison PJ, Goulding N, James I, Ahern MJ, Watt I, Sansom D. The Felty syndrome: a case-matched study of clinical manifestations and outcome, serologic features, and immunogenetic associations. Medicine. 1990 Mar:69(2):69-80
[PubMed PMID: 1969604]
Level 3 (low-level) evidence
[3]
Aslam F, Cheema RS, Feinstein M, Chang-Miller A. Neutropaenia and splenomegaly without arthritis: think rheumatoid arthritis. BMJ case reports. 2018 Jul 11:2018():. pii: bcr-2018-225359. doi: 10.1136/bcr-2018-225359. Epub 2018 Jul 11
[PubMed PMID: 30002215]
Level 3 (low-level) evidence
[4]
van der Helm-van Mil AH, Verpoort KN, Breedveld FC, Huizinga TW, Toes RE, de Vries RR. The HLA-DRB1 shared epitope alleles are primarily a risk factor for anti-cyclic citrullinated peptide antibodies and are not an independent risk factor for development of rheumatoid arthritis. Arthritis and rheumatism. 2006 Apr:54(4):1117-21
[PubMed PMID: 16572446]
[5]
Turesson C, Schaid DJ, Weyand CM, Jacobsson LT, Goronzy JJ, Petersson IF, Sturfelt G, Nyhäll-Wåhlin BM, Truedsson L, Dechant SA, Matteson EL. The impact of HLA-DRB1 genes on extra-articular disease manifestations in rheumatoid arthritis. Arthritis research & therapy. 2005:7(6):R1386-93
[PubMed PMID: 16277691]
[6]
Sibley JT, Haga M, Visram DA, Mitchell DM. The clinical course of Felty's syndrome compared to matched controls. The Journal of rheumatology. 1991 Aug:18(8):1163-7
[PubMed PMID: 1941816]
[7]
Bartels CM, Bell CL, Shinki K, Rosenthal A, Bridges AJ. Changing trends in serious extra-articular manifestations of rheumatoid arthritis among United State veterans over 20 years. Rheumatology (Oxford, England). 2010 Sep:49(9):1670-5. doi: 10.1093/rheumatology/keq135. Epub 2010 May 12
[PubMed PMID: 20463190]
[8]
Termini TE, Biundo JJ Jr, Ziff M. The rarity of Felty's syndrome in blacks. Arthritis and rheumatism. 1979 Sep:22(9):999-1005
[PubMed PMID: 475875]
[10]
Burks EJ, Loughran TP Jr. Pathogenesis of neutropenia in large granular lymphocyte leukemia and Felty syndrome. Blood reviews. 2006 Sep:20(5):245-66
[PubMed PMID: 16530306]
[11]
Hellmich B, Csernok E, Schatz H, Gross WL, Schnabel A. Autoantibodies against granulocyte colony-stimulating factor in Felty's syndrome and neutropenic systemic lupus erythematosus. Arthritis and rheumatism. 2002 Sep:46(9):2384-91
[PubMed PMID: 12355486]
[12]
Dwivedi N, Upadhyay J, Neeli I, Khan S, Pattanaik D, Myers L, Kirou KA, Hellmich B, Knuckley B, Thompson PR, Crow MK, Mikuls TR, Csernok E, Radic M. Felty's syndrome autoantibodies bind to deiminated histones and neutrophil extracellular chromatin traps. Arthritis and rheumatism. 2012 Apr:64(4):982-92. doi: 10.1002/art.33432. Epub 2011 Oct 27
[PubMed PMID: 22034172]
[13]
Liu X, Loughran TP Jr. The spectrum of large granular lymphocyte leukemia and Felty's syndrome. Current opinion in hematology. 2011 Jul:18(4):254-9. doi: 10.1097/MOH.0b013e32834760fb. Epub
[PubMed PMID: 21546829]
Level 3 (low-level) evidence
[14]
Owlia MB, Newman K, Akhtari M. Felty's Syndrome, Insights and Updates. The open rheumatology journal. 2014:8():129-36. doi: 10.2174/1874312901408010129. Epub 2014 Dec 31
[PubMed PMID: 25614773]
[15]
Liu JH, Wei S, Lamy T, Epling-Burnette PK, Starkebaum G, Djeu JY, Loughran TP. Chronic neutropenia mediated by fas ligand. Blood. 2000 May 15:95(10):3219-22
[PubMed PMID: 10807792]
[16]
Nozawa K, Kayagaki N, Tokano Y, Yagita H, Okumura K, Hasimoto H. Soluble Fas (APO-1, CD95) and soluble Fas ligand in rheumatic diseases. Arthritis and rheumatism. 1997 Jun:40(6):1126-9
[PubMed PMID: 9182923]
[17]
Prasad S, Mushfiq Farooqui I, AlZoubi L, Arami S. T-cell Large Granular Lymphocytic Leukemia and Felty Syndrome in Rheumatoid Arthritis: A Case Report. Cureus. 2023 Jul:15(7):e41780. doi: 10.7759/cureus.41780. Epub 2023 Jul 12
[PubMed PMID: 37575786]
Level 3 (low-level) evidence
[18]
Couette N, Jarjour W, Brammer JE, Simon Meara A. Pathogenesis and Treatment of T-Large Granular Lymphocytic Leukemia (T-LGLL) in the Setting of Rheumatic Disease. Frontiers in oncology. 2022:12():854499. doi: 10.3389/fonc.2022.854499. Epub 2022 Jun 7
[PubMed PMID: 35747794]
[19]
Gazitt T, Loughran TP Jr. Chronic neutropenia in LGL leukemia and rheumatoid arthritis. Hematology. American Society of Hematology. Education Program. 2017 Dec 8:2017(1):181-186. doi: 10.1182/asheducation-2017.1.181. Epub
[PubMed PMID: 29222254]
[20]
Armstrong RD, Fernandes L, Gibson T, Kauffmann EA. Felty's syndrome presenting without arthritis. British medical journal (Clinical research ed.). 1983 Nov 26:287(6405):1620
[PubMed PMID: 6416525]
[21]
Uchida S, Kawai K, Tsutsui Y, Yamazaki M. Felty syndrome in a patient with undiagnosed rheumatoid arthritis presenting with multiple cutaneous abscesses. The Journal of dermatology. 2022 Jun:49(6):e208-e209. doi: 10.1111/1346-8138.16332. Epub 2022 Feb 21
[PubMed PMID: 35187709]
[22]
Pararath Gopalakrishnan V, Tirupur Ponnusamy J, Panginikkod S. Felty Syndrome. QJM : monthly journal of the Association of Physicians. 2023 Oct 3:():. pii: hcad222. doi: 10.1093/qjmed/hcad222. Epub 2023 Oct 3
[PubMed PMID: 37788124]
[23]
Hoshina Y, Teaupa S, Chang D. Infective Endocarditis-Like Presentation of Felty Syndrome: A Case Report. Cureus. 2021 Dec:13(12):e20713. doi: 10.7759/cureus.20713. Epub 2021 Dec 26
[PubMed PMID: 34966628]
Level 3 (low-level) evidence
[24]
Nonaka K, Watanabe S, Sano C, Ohta R. Treating Exudative Pleurisy Accompanied by Felty Syndrome in an Older Patient With Advanced Rheumatoid Arthritis. Cureus. 2023 Apr:15(4):e37270. doi: 10.7759/cureus.37270. Epub 2023 Apr 7
[PubMed PMID: 37168154]
[25]
Sienknecht CW, Urowitz MB, Pruzanski W, Stein HB. Felty's syndrome. Clinical and serological analysis of 34 cases. Annals of the rheumatic diseases. 1977 Dec:36(6):500-7
[PubMed PMID: 596944]
Level 3 (low-level) evidence
[26]
Barnes CG, Turnbull AL, Vernon-Roberts B. Felty's syndrome. A clinical and pathological survey of 21 patients and their response to treatment. Annals of the rheumatic diseases. 1971 Jul:30(4):359-74
[PubMed PMID: 4104268]
Level 3 (low-level) evidence
[27]
Morikawa S, Miyashita Y, Nasu M, Shibazaki S, Usuda S, Tsunoda K, Nakagawa T. Severe alveolar bone resorption in Felty syndrome: a case report. Journal of medical case reports. 2022 Dec 16:16(1):463. doi: 10.1186/s13256-022-03703-1. Epub 2022 Dec 16
[PubMed PMID: 36522676]
Level 3 (low-level) evidence
[28]
Fiechtner JJ, Miller DR, Starkebaum G. Reversal of neutropenia with methotrexate treatment in patients with Felty's syndrome. Correlation of response with neutrophil-reactive IgG. Arthritis and rheumatism. 1989 Feb:32(2):194-201
[PubMed PMID: 2920054]
[29]
Wassenberg S, Herborn G, Rau R. Methotrexate treatment in Felty's syndrome. British journal of rheumatology. 1998 Aug:37(8):908-11
[PubMed PMID: 9734684]
[30]
Isasi C, López-Martín JA, Angeles Trujillo M, Andreu JL, Palacio S, Mulero J. Felty's syndrome: response to low dose oral methotrexate. The Journal of rheumatology. 1989 Jul:16(7):983-5
[PubMed PMID: 2504919]
[31]
Talip F, Walker N, Khan W, Zimmermann B. Treatment of Felty's syndrome with leflunomide. The Journal of rheumatology. 2001 Apr:28(4):868-70
[PubMed PMID: 11327265]
[32]
Dillon AM, Luthra HS, Conn DL, Ferguson RH. Parenteral gold therapy in the Felty syndrome. Experience with 20 patients. Medicine. 1986 Mar:65(2):107-12
[PubMed PMID: 3951357]
[33]
Canvin JM, Dalal BI, Baragar F, Johnston JB. Cyclosporine for the treatment of granulocytopenia in Felty's syndrome. American journal of hematology. 1991 Mar:36(3):219-20
[PubMed PMID: 1996561]
[34]
Yazıcı A, Uçar A, Mehtap Ö, Gönüllü EÖ, Tamer A. Presentation of three cases followed up with a diagnosis of Felty syndrome. European journal of rheumatology. 2014 Sep:1(3):120-122
[PubMed PMID: 27708892]
Level 3 (low-level) evidence
[35]
Chandra PA, Margulis Y, Schiff C. Rituximab is useful in the treatment of Felty's syndrome. American journal of therapeutics. 2008 Jul-Aug:15(4):321-2. doi: 10.1097/MJT.0b013e318164bf32. Epub
[PubMed PMID: 18645332]
[36]
Narváez J, Domingo-Domenech E, Gómez-Vaquero C, López-Vives L, Estrada P, Aparicio M, Martín-Esteve I, Nolla JM. Biological agents in the management of Felty's syndrome: a systematic review. Seminars in arthritis and rheumatism. 2012 Apr:41(5):658-68. doi: 10.1016/j.semarthrit.2011.08.008. Epub 2011 Nov 25
[PubMed PMID: 22119104]
Level 1 (high-level) evidence
[37]
Job-Deslandre C, Menkès CJ. Treatment of Felty's syndrome with auranofin and methylprednisolone. Arthritis and rheumatism. 1989 Sep:32(9):1188-9
[PubMed PMID: 2775326]
[38]
Hellmich B, Schnabel A, Gross WL. Treatment of severe neutropenia due to Felty's syndrome or systemic lupus erythematosus with granulocyte colony-stimulating factor. Seminars in arthritis and rheumatism. 1999 Oct:29(2):82-99
[PubMed PMID: 10553980]
[39]
Laszlo J, Jones R, Silberman HR, Banks PM. Splenectomy for Felty's syndrome. Clinicopathological study of 27 patients. Archives of internal medicine. 1978 Apr:138(4):597-602
[PubMed PMID: 637640]
[40]
Coon WW. Felty's syndrome: when is splenectomy indicated? American journal of surgery. 1985 Feb:149(2):272-5
[PubMed PMID: 3970327]
[41]
Savola P, Bhattacharya D, Huuhtanen J. The spectrum of somatic mutations in large granular lymphocyte leukemia, rheumatoid arthritis, and Felty's syndrome. Seminars in hematology. 2022 Jul:59(3):123-130. doi: 10.1053/j.seminhematol.2022.07.004. Epub 2022 Aug 3
[PubMed PMID: 36115688]
[42]
Moosic KB, Ananth K, Andrade F, Feith DJ, Darrah E, Loughran TP Jr. Intersection Between Large Granular Lymphocyte Leukemia and Rheumatoid Arthritis. Frontiers in oncology. 2022:12():869205. doi: 10.3389/fonc.2022.869205. Epub 2022 May 13
[PubMed PMID: 35646651]
[43]
Hamsho S, Alannouf I, Ashour AA. Rapidly Progressive Felty Syndrome After Sudden Discontinuation of Methotrexate: A Case Report and Review of Literature. International medical case reports journal. 2022:15():473-477. doi: 10.2147/IMCRJ.S365004. Epub 2022 Sep 2
[PubMed PMID: 36091198]
Level 3 (low-level) evidence
[44]
Ward MM. Decreases in rates of hospitalizations for manifestations of severe rheumatoid arthritis, 1983-2001. Arthritis and rheumatism. 2004 Apr:50(4):1122-31
[PubMed PMID: 15077294]
[45]
Thorne C, Urowitz MB. Long-term outcome in Felty's syndrome. Annals of the rheumatic diseases. 1982 Oct:41(5):486-9
[PubMed PMID: 7125718]